(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Crispr Therapeutics is 1320370
| Date | Daily Closing Price | Open | High | Low | Volume |
| 02 Thu May 2024 | 55.07 | 54.48 | 55.34 | 53.99 | 0.761 times |
| 01 Wed May 2024 | 53.81 | 53.16 | 55.97 | 52.74 | 1.017 times |
| 30 Tue Apr 2024 | 52.99 | 53.90 | 54.44 | 52.73 | 0.848 times |
| 29 Mon Apr 2024 | 54.83 | 54.09 | 55.62 | 54.00 | 1.115 times |
| 26 Fri Apr 2024 | 53.91 | 54.21 | 54.94 | 52.81 | 1.025 times |
| 25 Thu Apr 2024 | 53.73 | 53.98 | 54.15 | 52.75 | 0.946 times |
| 24 Wed Apr 2024 | 55.65 | 56.79 | 57.78 | 55.50 | 0.697 times |
| 23 Tue Apr 2024 | 56.41 | 55.93 | 58.68 | 55.56 | 0.902 times |
| 22 Mon Apr 2024 | 55.66 | 55.40 | 56.93 | 54.37 | 0.791 times |
| 19 Fri Apr 2024 | 55.05 | 56.16 | 57.50 | 54.28 | 1.338 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 53.9 as stoploss in an intra day buy trade for a target of 57.65. However, stock will show a bearish move below 53.9.
Share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Target | 52.73 |
| Downside Target | 54.28 |
| Upside Target | 55.97 |
| Upside Target | 58.29 |
| Upside Target | 60.25 |
| Upside Target | 65.24 |
| Upside Target | 67.52 |
| Upside Target | 68.39 |
| Upside Target | 68.48 |
| Upside Target | 87.08 |
| Upside Target | 91.10 |
Intraday share price targets for Crispr Therapeutics (CRSP)
| Target Type | Value |
| Downside Intraday Target | 53.21 |
| Downside Intraday Target | 51.35 |
| Upside Intraday Target | 56.45 |
| Upside Intraday Target | 57.83 |
| Downside Intraday Target | 54.59 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 02 Thu May 2024 | 55.07 | 54.09 | 55.97 | 52.73 | 0.858 times |
| 26 Fri Apr 2024 | 53.91 | 55.40 | 58.68 | 52.75 | 0.762 times |
| 19 Fri Apr 2024 | 55.05 | 60.74 | 60.95 | 54.28 | 1.213 times |
| 12 Fri Apr 2024 | 60.67 | 63.21 | 65.24 | 60.25 | 0.962 times |
| 05 Fri Apr 2024 | 62.90 | 68.14 | 68.39 | 62.33 | 1.381 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 02 Thu May 2024 | 55.07 | 53.16 | 55.97 | 52.74 | 0.082 times |
| 30 Tue Apr 2024 | 52.99 | 68.14 | 68.39 | 52.73 | 1.058 times |
| 28 Thu Mar 2024 | 68.16 | 84.36 | 87.08 | 67.52 | 0.53 times |
| 29 Thu Feb 2024 | 84.22 | 63.49 | 91.10 | 62.08 | 1.159 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 54.68 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 54.68 and Crispr Therapeutics (CRSP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.